Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Ther Targets. 2005 Feb;9(1):153-68.

GABA and glutamate systems as therapeutic targets in depression and mood disorders.

Author information

1
Yale University School of Medicine, Department of Psychiatry, 333 Cedar Street, New Haven, CT 06510, USA.

Abstract

Advances made in diverse areas of neuroscience suggest that neurotransmitter systems, additional to the monoaminergic, contribute to the pathophysiology of mood disorders. This ever accruing body of preclinical and clinical research is providing increased recognition of the contribution made by amino acid neurotransmitters to the neurobiology of mood disorders. This review examines evidence supporting the role of GABA and glutamate in these processes and explores the potential to target these systems in the development of novel compounds; the viability of these agents for treatment-related co-morbidities will also be considered.

PMID:
15757488
DOI:
10.1517/14728222.9.1.153
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center